![](https://d3ilqtpdwi981i.cloudfront.net/bNXF7vgmbBjuwSk1TC3o9_cRgQM=/0x0:591x765/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/28/3a/ef/283aefe4-c99d-4694-b3af-effeeb3cd1ba/mt.jpg)
Article
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
Molecular Therapy
(2016)
Disciplines
Publication Date
June 1, 2016
DOI
10.1038/mt.2016.66
Citation Information
Anne M. Noonan, Matthew R. Farren, Susan M. Geyer, Ying Huang, et al.. "Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma" Molecular Therapy Vol. 24 Iss. 6 (2016) p. 1150 - 1158 Available at: http://works.bepress.com/santiago-aparo/26/